A Single Immunization With Modified Vaccinia Virus Ankara-Based Influenza Virus H7 Vaccine Affords Protection in the Influenza A(H7N9) Pneumonia Ferret Model

Divergent H7 Immunogens Offer Protection from H7N9 Virus Challenge

(2014) F. Krammer et al.   JOURNAL OF VIROLOGY

Development of a High-Yield Live Attenuated H7N9 Influenza Virus Vaccine That Provides Protection against Homologous and Heterologous H7 Wild-Type Viruses in Ferrets

(2014) Z. Chen et al.   JOURNAL OF VIROLOGY

MVA Vectors Expressing Conserved Influenza Proteins Protect Mice against Lethal Challenge with H5N1, H9N2 and H7N1 Viruses

(2014) Annett Hessel et al.   PLoS One

Protective immunity to H7N9 influenza viruses elicited by synthetic DNA vaccine

(2014) Jian Yan et al.   VACCINE

Potency of an inactivated influenza vaccine prepared from A/duck/Mongolia/119/2008 (H7N9) against the challenge with A/Anhui/1/2013 (H7N9)

(2014) Duc-Huy Chu et al.   VACCINE

H7N9: a low pathogenic avian influenza A virus infecting humans

(2014) Jun Liu et al.   Current Opinion in Virology

Optimal designs of an HA-based DNA vaccine against H7 subtype influenza viruses

(2014) Lu Zhang et al.   Human Vaccines & Immunotherapeutics

Novel Avian-Origin Influenza A (H7N9) Virus Attaches to Epithelium in Both Upper and Lower Respiratory Tract of Humans

(2013) Debby van Riel et al.   AMERICAN JOURNAL OF PATHOLOGY

Novel Avian-Origin Human Influenza A(H7N9) Can Be Transmitted Between Ferrets via Respiratory Droplets

(2013) Lili Xu et al.   JOURNAL OF INFECTIOUS DISEASES

Induction of Cross-Reactive Antibodies to Novel H7N9 Influenza Virus by Recombinant Newcastle Disease Virus Expressing a North American Lineage H7 Subtype Hemagglutinin

(2013) P. H. Goff et al.   JOURNAL OF VIROLOGY

Limited airborne transmission of H7N9 influenza A virus between ferrets

(2013) Mathilde Richard et al.   NATURE

A Recombinant Viruslike Particle Influenza A (H7N9) Vaccine

(2013) Louis F. Fries et al.   NEW ENGLAND JOURNAL OF MEDICINE

Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus

(2013) Rongbao Gao et al.   NEW ENGLAND JOURNAL OF MEDICINE

Evaluation of Live Attenuated H7N3 and H7N7 Vaccine Viruses for Their Receptor Binding Preferences, Immunogenicity in Ferrets and Cross Reactivity to the Novel H7N9 Virus

(2013) Qi Xu et al.   PLoS One

Reflections on the early development of poxvirus vectors

(2013) Bernard Moss   VACCINE

Poxvirus vectors

(2013) Joost H.C.M. Kreijtz et al.   VACCINE

Low pathogenic avian influenza A(H7N9) virus causes high mortality in ferrets upon intratracheal challenge: A model to study intervention strategies

(2013) J.H.C.M. Kreijtz et al.   VACCINE

Cross-protective immunity against multiple influenza virus subtypes by a novel modified vaccinia Ankara (MVA) vectored vaccine in mice

(2013) Joseph N. Brewoo et al.   VACCINE

One-shot vaccination with an insect cell-derived low-dose influenza A H7 virus-like particle preparation protects mice against H7N9 challenge

(2013) Miriam Klausberger et al.   VACCINE

Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis

(2013) E. Miller et al.   BMJ-British Medical Journal

Low immunogenicity predicted for emerging avian-origin H7N9

(2013) Anne S. De Groot et al.   Human Vaccines & Immunotherapeutics

The Multibasic Cleavage Site in H5N1 Virus Is Critical for Systemic Spread along the Olfactory and Hematogenous Routes in Ferrets

(2012) E. J. A. Schrauwen et al.   JOURNAL OF VIROLOGY

Evaluations for In Vitro Correlates of Immunogenicity of Inactivated Influenza A H5, H7 and H9 Vaccines in Humans

(2012) Robert B. Couch et al.   PLoS One

Pathogenesis of Influenza A/H5N1 Virus Infection in Ferrets Differs between Intranasal and Intratracheal Routes of Inoculation

(2011) Rogier Bodewes et al.   AMERICAN JOURNAL OF PATHOLOGY

Efficacy of Vaccination with Different Combinations of MF59-Adjuvanted and Nonadjuvanted Seasonal and Pandemic Influenza Vaccines against Pandemic H1N1 (2009) Influenza Virus Infection in Ferrets

(2011) J. M. A. van den Brand et al.   JOURNAL OF VIROLOGY

Vectors Based on Modified Vaccinia Ankara Expressing Influenza H5N1 Hemagglutinin Induce Substantial Cross-Clade Protective Immunity

(2011) Annett Hessel et al.   PLoS One

Recipients of Vaccine against the 1976 “Swine Flu” Have Enhanced Neutralization Responses to the 2009 Novel H1N1 Influenza Virus

(2010) Jonathan A. McCullers et al.   CLINICAL INFECTIOUS DISEASES

Potent CD8+ T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA-NP+M1

(2010) T. K. Berthoud et al.   CLINICAL INFECTIOUS DISEASES

Vaccination strategies and vaccine formulations for epidemic and pandemic influenza control

(2010) Joost H.C.M. Kreijtz et al.   Human vaccines & immunotherapeutics

Evaluation of a modified vaccinia virus Ankara (MVA)-based candidate pandemic influenza A/H1N1 vaccine in the ferret model

(2010) J. H. C. M. Kreijtz et al.   JOURNAL OF GENERAL VIROLOGY

Repository of Eurasian influenza A virus hemagglutinin and neuraminidase reverse genetics vectors and recombinant viruses

(2010) J. Keawcharoen et al.   VACCINE

Candidate influenza vaccines based on recombinant modified vaccinia virus Ankara

(2009) Guus F Rimmelzwaan et al.   Expert Review of Vaccines

MVA-Based H5N1 Vaccine Affords Cross-Clade Protection in Mice against Influenza A/H5N1 Viruses at Low Doses and after Single Immunization

(2009) Joost H. C. M. Kreijtz et al.   PLoS One

Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza

(2009) Nicolas Collin et al.   VACCINE

Preclinical evaluation of a modified vaccinia virus Ankara (MVA)-based vaccine against influenza A/H5N1 viruses

(2009) J.H.C.M. Kreijtz et al.   VACCINE

Recombinant Modified Vaccinia Virus Ankara Expressing the Hemagglutinin Gene Confers Protection against Homologous and Heterologous H5N1 Influenza Virus Infections in Macaques

(2008) J. H. C. M. Kreijtz et al.   JOURNAL OF INFECTIOUS DISEASES

Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions

(2008) Jutta Veits et al.   VACCINE